Immunotherapy with histamine dihydrochloride and low-dose interleukin-2 favors sustained lymphocyte recovery in acute myeloid leukemia

被引：5
|
作者：
Hallner, Alexander [1 ]
Aurelius, Johan [1 ]
Thoren, Fredrik Bergh [1 ]
Sander, Frida Ewald [1 ]
Brune, Mats [1 ]
Hellstrand, Kristoffer [1 ]
Martner, Anna [1 ]
机构：
[1] Univ Gothenburg, Sahlgrenska Canc Ctr, S-40530 Gothenburg, Sweden
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2015年 / 94卷 / 03期
关键词：
D O I：
10.1111/ejh.12454
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：279 / 280
页数：2
相关论文
共 50 条
  • [1] Immunotherapy with histamine dihydrochloride and low-dose interleukin-2 favors sustained lymphocyte recovery in acute myeloid leukemia (vol 94, pg 278, 2015)
    Hallner, A.
    Aurelius, J.
    Thoren, F. B.
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (01) : 99 - 99
  • [2] Histamine dihydrochloride and low-dose interleukin-2 as post-consolidation immunotherapy in acute myeloid leukemia
    Thoren, Fredrik B.
    Romero, Ana I.
    Brune, Mats
    Hellstrand, Kristoffer
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (09) : 1217 - 1223
  • [3] Relapse Prevention in Acute Myeloid Leukemia: The Role of Immunotherapy with Histamine Dihydrochloride and Low-Dose Interleukin-2
    Montesinos, Pau
    Buccisano, Francesco
    Cluzeau, Thomas
    Vennstroem, Lovisa
    Heuser, Michael
    [J]. CANCERS, 2024, 16 (10)
  • [4] Histamine dihydrochloride and interleukin-2 in the treatment of acute myeloid leukemia
    Stadtmauer, EA
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (03) : 47 - 51
  • [5] Histamine dihydrochloride and interleukin-2 in acute myeloid leukemia - Background and results
    Brune M.
    Romero A.I.
    Hellstrand K.
    [J]. Inflammation Research, 2009, 58 (Suppl 1) : S4 - S8
  • [6] Age-Related Efficacy of Immunotherapy with Histamine Dihydrochloride and Interleukin-2 for Relapse Prevention in Acute Myeloid Leukemia
    Hellstrand, K.
    Thoren, F. B.
    Martner, A.
    Soderholm, J.
    Hofmann, W. K.
    Rowe, J. M.
    Brune, M.
    [J]. ANNALS OF HEMATOLOGY, 2011, 90 : S30 - S32
  • [7] Impact on quality of life of postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myelogenous leukemia
    Wallhult, Elisabeth
    Whisnant, John
    Rowe, Jacob M.
    Szer, Jeff
    Bhagwat, Dileep
    Hellstrand, Kristoffer
    Nilsson, Bo I.
    Brune, Mats L.
    [J]. BLOOD, 2007, 110 (11) : 163B - 164B
  • [8] Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia
    Martner, Anna
    Thoren, Fredrik B.
    Aurelius, Johan
    Soderholm, Jonas
    Brune, Mats
    Hellstrand, Kristoffer
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2010, 3 (04) : 381 - 391
  • [9] Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial
    Brune, Mats
    Castaigne, Sylvie
    Catalano, John
    Gehlsen, Kurt
    Ho, Anthony D.
    Hofmann, Wolf-Karsten
    Hogge, Donna E.
    Nilsson, Bo
    Or, Reuven
    Romero, Ana I.
    Rowe, Jacob M.
    Simonsson, Bengt
    Spearing, Ruth
    Stadtmauer, Edward A.
    Szer, Jeff
    Wallhult, Elisabeth
    Hellstrand, Kristoffer
    [J]. BLOOD, 2006, 108 (01) : 88 - 96
  • [10] Sustained complete remission of recurrent acute myeloid leukaemia with a single dose of gemtuzumab ozogamicin and low-dose interleukin-2 maintenance
    MP Radsak
    HR Salih
    M Sökler
    L Kanz
    C Denzlinger
    [J]. Leukemia, 2002, 16 : 1870 - 1871
12345